Puma Biotechnology Inc (NASDAQ: PBYI) Stock Information | RedChip

Puma Biotechnology Inc (NASDAQ: PBYI) Listen to this Section


$2.70
+0.0500 ( +1.89% ) 380.0K

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Market Data


Open


$2.70

Previous close


$2.65

Volume


380.0K

Market cap


$132.18M

Day range


$2.65 - $2.78

52 week range


$2.13 - $7.73

Insider Ownership Transactions

Total Amount Purchased: -353,643.00 | $ -954,836.10

Date Type Amount Purchased Purchaser
2024-06-17 Sale -11000.00 Dorval Allison
2024-03-19 Sale -6577.00 AUERBACH ALAN H
2024-02-14 Sale -37894.00 HUNT DOUGLAS M
2024-02-14 Sale -160796.00 AUERBACH ALAN H
2024-02-14 Sale -27067.00 Ludwig Jeffrey Jerome
2024-02-14 Sale -43307.00 NOUGUES MAXIMO F
2024-02-14 Sale -43307.00 Wong Alvin F
2024-01-10 Sale -280.00 Wong Alvin F
2024-01-05 Sale -15682.00 NOUGUES MAXIMO F
2024-01-05 Sale -7733.00 Wong Alvin F

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 14 May 17, 2024
10-q Quarterly Reports 83 May 02, 2024
8-k 8K-related 16 May 02, 2024
ars Annual reports 1 Apr 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.